In 2023, Fred P. Lampropoulos earned $6.01M in total compensation at Merit Medical Systems, including $1.89M salary, $1.34M bonus and $2.77M in stock. Most recently sold 68,639 shares in Mar 2025. Currently holds stock worth $85.84M. Has donated $994.40K in stock to charitable causes. Has led Merit Medical Systems for over 10 years.
Compensation History
Annual executive compensation data for Fred P. Lampropoulos, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$6.01M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Salary
$1.89MBoard Justification
The compensation philosophy is to align the interests of management and shareholders for the purpose of maximizing shareholder value, while considering the interests of other significant stakeholders such as employees, patients, customers, business partners and the communities in which we operate.
Bonus
$1.34MBoard Justification
Based on the Company’s achievement of goals established by the Compensation Committee, the Compensation Committee determined to award and pay the annual cash bonus at 118.12% of the target payment amount for 2023.
Other Compensation
$8.70KBoard Justification
Includes matching contributions made by the Company for the benefit of Mr. Lampropoulos to the Company’s 401(k) Plan.
Restricted Stock
Board Justification
Represents the number of shares of stock that vested in 2023 under the performance stock units (PSUs) granted in prior years, based on the achievement of performance metrics.
Performance Metrics
The performance metrics for determining the compensation of the CEO include total shareholder return, net sales, non-GAAP operating margin, non-GAAP earnings per share, and adjusted free cash flow.
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of Merit Medical Systems for
10 years 0 months (Dec 2015 - Present)
Previous Experience
President of Merit Medical Systems Inc.
Holdings
Track Fred P. Lampropoulos's stock holdings and portfolio value over time.
Total Stock Sold
$18.38M
$18.38M
396,889.484 MMSI shares
What if they kept their stock?
If Fred P. Lampropoulos didn't sell their stock, today they would have:
Extra MMSI396,889.484 shares worth $33.40M.
This is 81.67% and $15.01M more than what they got when they sold the stock.
Charitable Transactions
11,817 shares
MMSI
Recent Charitable Transactions
11,817 shares
MMSI
Mar 6, 2015
Charity
Insider Trading
Fred P. Lampropoulos's recent stock transactions, purchases, and sales filed with the SEC.
$7.13M
MMSI at $103.82/share
Mar 5, 2025
Sale
102,278 shares
MMSI
Feb 27, 2025
Received
43,534 shares
MMSI
Mar 4, 2024
Received
$1.70M
MMSI at $68.04/share
Mar 14, 2023
Sale
$1.45M
MMSI at $70.02/share
Feb 28, 2023
Sale
27,159 shares
MMSI
Feb 28, 2023
Received
17,680 shares
MMSI
Feb 26, 2022
Received
$294.84K
MMSI at $59.60/share
Mar 12, 2021
Sale
8,840 shares
MMSI
Feb 26, 2021
Received
$220.00K
MMSI at $44.00/share
May 20, 2020
Sale
Rivals
Compare Fred P. Lampropoulos with competitor CEOs and industry peers.
August J. Troendle
Founder and CEO of Medpace Holdings, Inc.
2023 Compensation
Stock
$0.00
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Total Holdings
$513.58M
Joseph W. Dziedzic
CEO of Integer Holdings
2022 Compensation
Stock
$0.00
Salary
$1.23M
Bonus
$0.00
Other
$97.75K
Total Holdings
$77.20M
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Gail K. Boudreaux
CEO of Elevance Health
2023 Compensation
Stock
$0.00
Salary
$1.60M
Bonus
$3.65M
Other
$840.96K
Total Holdings
$23.73K
R. Dirk Allison
CEO of Addus HomeCare
2023 Compensation
Stock
$0.00
Salary
$940.39K
Bonus
$1.33M
Other
$24.47K
Total Holdings
$15.78M